Recruiting

Cancer & Immune Cells

Sponsor:

New Mexico Cancer Research Alliance

Code:

NCT03943316

Conditions

Ovarian Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Ascites samples from women undergoing surgery for ovarian cancer will be collected for use in translational research.

Conditions

Ovarian Cancer

Study ID

NCT03943316

Start date

Dec 2, 2015

Status verified date

May, 2025

Completion date

Dec 31, 2027

Anticipated

Primary completion date

Dec 31, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All female participants, regardless of ethnicity, who are undergoing cytoreductive surgery for ovarian cancer are eligible for this study
  • All participants will be eighteen years old or older
  • Patients must be suspected of having a pathological diagnosis or clinical suspicion of ovarian cancer and be scheduled for surgery for tumor resection.
  • Ability to understand and the willingness to sign a written informed consent document.
  • Pathologic confirmation of a diagnosis of epithelial adenocarcinoma of the ovary, fallopian tube, or primary peritoneal cancer (serous, mucinous, clear cell, endometrioid, undifferentiated, mixed, transitional cell)
  • Women of childbearing potential must have a negative qualitative serum pregnancy test ≤ 2 weeks prior to study entry.
  • A female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:

  • Has not undergone a hysterectomy or bilateral oophorectomy; or
  • Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).

Exclusion Criteria:

  • We do not intend to include participants if they are unable to provide informed consent for this study themselves (e.g. mentally ill patients who require health care proxies to consent for any medical intervention), or vulnerable populations such as prisoners.
  • Minors under age eighteen.
  • Pregnant women.
  • Final pathologic diagnosis that does not confirm invasive epithelial ovarian, tubal, or primary peritoneal cancer

Study Design

Enrollment

100 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Collect ascites fluid obtained from ovarian cancer patients during cytoreductive surgery or paracentesis [ Time Frame: 5 years ]

Central Contacts and Locations

Central contacts

Sarah Adams, MD

(505) 925-0461SAdams@salud.unm.edu

Amy Overby

505-272-5557Aoverby1@salud.unm.edu

Locations

University of New Mexico Cancer Center

Recruiting

Albuquerque, New Mexico, United States, 87131

Contacts

Amy Overby

505-272-5557Aoverby1@salud.unm.edu

Sharareh Sazesh, MS

ssazesh@salud.unm.edu

Principal Investigator:

Sarah Adams, MD

More Information

Sponsor

New Mexico Cancer Research Alliance

Last update posted

May 22, 2025

Last verified

May, 2025

Keywords

  • Ovarian Cancer
  • Ascites

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by New Mexico Cancer Research Alliance on 2025-05-22.